Clinical Trial Update: The G Protein-Coupled Receptor Kinase Type 2 Inhibitor Paroxetine as Adjunctive Therapy to Improve Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating paroxetine as adjunctive therapy to improve insulin sensitivity in adults with type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Paroxetine (Paroxetine hydrochloride)

Snippet

Sponsor: aya ramadan ashmawy sarhan | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: UNKNOWN